Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
| Sales | 1,659,506 | 1,506,500 | 1,414,278 | 1,279,200 | 1,407,677 |
| Cost of Goods | 430,550 | 381,000 | 358,000 | 363,000 | 642,350 |
| Gross Profit | 1,181,360 | 1,040,000 | 985,000 | 899,000 | 1,649,820 |
| Operating Expenses | 852,510 | 684,000 | 638,000 | 648,000 | 1,191,530 |
| Operating Income | 376,996 | 441,500 | 418,278 | 268,200 | -425,853 |
| Interest Expense | -61,000 | 17,000 | 31,000 | 13,000 | 0 |
| Other Income | -143,926 | -34,500 | -7,278 | 55,800 | 1,014,163 |
| Pre-tax Income | 294,070 | 390,000 | 380,000 | 311,000 | 588,310 |
| Income Tax | 84,790 | 107,000 | 107,000 | 97,000 | 192,140 |
| Net Income Continuous | 210,500 | 300,118 | 287,459 | 217,792 | 259,066 |
| Net Income | $210,500 | $300,118 | $287,459 | $217,792 | $259,066 |
| EPS Basic Total Ops | 0.03 | 0.05 | 0.04 | 0.03 | 0.04 |
| EPS Basic Continuous Ops | 0.03 | 0.05 | 0.04 | 0.03 | 0.04 |
| EPS Diluted Total Ops | 0.03 | 0.05 | 0.04 | 0.03 | 0.04 |
| EPS Diluted Continuous Ops | 0.03 | 0.05 | 0.04 | 0.03 | 0.04 |
| EBITDA(a) | $699,306 | $441,500 | $418,278 | $268,200 | $-109,893 |